STARTUP PROFILE

Manava Plus

COUNTRY
Italy
FOUNDED
2022
CATEGORY
Neuromodulation
Developing implantable neural prostheses for spinal cord injury that aim to reconnect damaged pathways and restore motor and sensory function.
Visit website →
Neurofounders Insights
$   Funding   -
Non-dilutive
MODALITY
SCS
FORM FACTOR
Implant
INTERFACE DEPTH
Implantable
INDICATION
Paralysis/motor
TARGET USER
Patients
REGULATORY STAGE
Preclinical
Manava Plus is developing implantable spinal neuroprostheses for spinal cord injury, targeting restoration of motor and sensory pathways rather than symptomatic management alone. This places it in the restorative neurotechnology segment, though still at an early preclinical stage.
Mentioned in Market Notes
MOST RECENT COVERAGE
No items found.
Articles featuring
Manava Plus
No items found.